isothiocyanic acid has been researched along with Skin Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adhikary, G; Eckert, RL; Gates, EWJ; Godoy-Ruiz, R; Keillor, JW; Lakowicz, JR; Puranik, P; Rorke, EA; Szmacinski, H; Weber, DJ | 1 |
| Amin, S; Crampsie, MA; Prakasha Gowda, AS; Sharma, AK; Sk, UH; Spratt, TE; Yun, JK | 1 |
2 other study(ies) available for isothiocyanic acid and Skin Neoplasms
| Article | Year |
|---|---|
Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity.
Topics: Animals; Antineoplastic Agents; Binding Sites; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Isothiocyanates; Mice; Models, Molecular; Protein Binding; Protein Conformation; Protein Glutamine gamma Glutamyltransferase 2; Skin Neoplasms; Sulfoxides; Xenograft Model Antitumor Assays | 2022 |
Development of novel naphthalimide derivatives and their evaluation as potential melanoma therapeutics.
Topics: Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Flow Cytometry; Humans; Hydrophobic and Hydrophilic Interactions; Injections, Intraperitoneal; Isothiocyanates; Melanoma; Mice; Mice, Nude; Naphthalimides; Neoplasm Transplantation; Skin Neoplasms; Structure-Activity Relationship; Thiourea | 2011 |